Evidence map›Paper›PMID 41790343›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2026

Use of reverse dot blot hybridization DNA-array and targeted next-generation sequencing for the detection of drug resistance in patients with tuberculosis: a prospective diagnostic accuracy study.

Andrii Dudnyk, Nadiia Tytarenko, Iris Romero Andrada, Oksana Lytvyniuk, Olena Tolstova, Joan-Pau Millet, Xavier Casas, Adrian Antuori, Nelly Ciobanu, Valeriu Crudu and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Andrii DudnykGermans Trias i Pujol Research Institute (IGTP), Badalona, Barcelona, Spain. andriidudnyk@vnmu.edu.ua.ORCID http://orcid.org/0000-0002-8780-9480
Nadiia TytarenkoGermans Trias i Pujol Research Institute (IGTP), Badalona, Barcelona, Spain.
Iris Romero AndradaGermans Trias i Pujol Research Institute (IGTP), Badalona, Barcelona, Spain.
Oksana LytvyniukDepartment of Tuberculosis, Clinical Immunology and Allergy, National Pirogov Memorial Medical University, Vinnytsia, Ukraine.
Olena TolstovaMicrobiology Laboratory, Regional Phthisiopulmonology Center, Vinnytsia, Ukraine.
Joan-Pau MilletServeis Clinics, Barcelona, Spain.
Xavier CasasServeis Clinics, Barcelona, Spain.
Adrian AntuoriGermans Trias i Pujol Research Institute (IGTP), Badalona, Barcelona, Spain.
Nelly CiobanuPMSI Institute of Pneumology "Chiril Draganiuc", Chișinău, Moldova.
Valeriu CruduPMSI Institute of Pneumology "Chiril Draganiuc", Chișinău, Moldova.
José DomínguezGermans Trias i Pujol Research Institute (IGTP), Badalona, Barcelona, Spain.

Funding

European Cooperation Science and Technology COST Action CA21164European Union's Horizon 2020 Research and Innovation Programme under the Marie Skłodowska-Curie grant agreement 823854Instituto de Salud Carlos III PI19/01408, PI22/01834MSCA4Ukraine project 1233336
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Drug resistanceMolecular diagnosticsReverse dot blot hybridization DNA-arrayTargeted next-generation sequencingTuberculosis

Identifiers

PMID41790343
PMCPMC13319130

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.